- Home
- CGEN vs HRZN Comparison
CGEN vs HRZN Comparison
Compare CGEN & HRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CGEN | HRZN |
|---|---|---|
| Founded | 1993 | 2008 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 270.4M | 286.0M |
| IPO Year | 2001 | N/A |
Fundamental Metrics
Financial Performance| Metric | CGEN | HRZN |
|---|---|---|
| Price | $2.26 | $4.65 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 5 |
| Target Price | $5.00 | ★ $6.50 |
| AVG Volume (30 Days) | 513.4K | ★ 843.0K |
| Earning Date | 05-18-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 33.85% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $12.25 |
| Revenue Next Year | $75.09 | $22.53 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.30 | $3.80 |
| 52 Week High | $3.24 | $8.46 |
Technical Indicators
Market Signals| Indicator | CGEN | HRZN |
|---|---|---|
| Relative Strength Index (RSI) | 36.01 | 64.54 |
| Support Level | $1.46 | $3.93 |
| Resistance Level | $2.35 | $4.82 |
| Average True Range (ATR) | 0.18 | 0.16 |
| MACD | -0.06 | 0.06 |
| Stochastic Oscillator | 3.64 | 96.77 |
Price Performance
Historical ComparisonAbout CGEN Compugen Ltd.
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.
About HRZN Horizon Technology Finance Corporation
Horizon Technology Finance Corp is a specialty finance company. Its investment objective is to maximize its investment portfolio's total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services, and sustainability industries.